These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27261671)

  • 1. Computational modeling of Repeat1 region of INI1/hSNF5: An evolutionary link with ubiquitin.
    Bhutoria S; Kalpana GV; Acharya SA
    Protein Sci; 2016 Sep; 25(9):1593-604. PubMed ID: 27261671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication.
    Dixit U; Bhutoria S; Wu X; Qiu L; Spira M; Mathew S; Harris R; Adams LJ; Cahill S; Pathak R; Rajesh Kumar P; Nguyen M; Acharya SA; Brenowitz M; Almo SC; Zou X; Steven AC; Cowburn D; Girvin M; Kalpana GV
    Nat Commun; 2021 May; 12(1):2743. PubMed ID: 33980829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex.
    Sammak S; Allen MD; Hamdani N; Bycroft M; Zinzalla G
    FEBS J; 2018 Nov; 285(22):4165-4180. PubMed ID: 30222246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
    Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
    Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
    Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
    PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-Protein and Protein-RNA Interaction Assays to Determine Similarity of INI1/SMARCB1 and TAR RNA in Binding to HIV-1 Integrase.
    Kalpana GV
    Methods Mol Biol; 2023; 2610():85-97. PubMed ID: 36534284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.
    Das S; Cano J; Kalpana GV
    J Biol Chem; 2009 Jul; 284(30):19903-14. PubMed ID: 19398554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.
    Wu DY; Tkachuck DC; Roberson RS; Schubach WH
    J Biol Chem; 2002 Aug; 277(31):27706-15. PubMed ID: 12016208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
    Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
    J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a monoclonal antibody for INI1/hSNF5/BAF47.
    Harada A; Hayashi M; Kuniyoshi Y; Semba Y; Sugahara S; Tachibana T; Ohkawa Y; Fujita M
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):49-51. PubMed ID: 24555937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region.
    Morozov A; Yung E; Kalpana GV
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1120-5. PubMed ID: 9448295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
    Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
    Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
    Medjkane S; Novikov E; Versteege I; Delattre O
    Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Coil-to-Helix Transition Serves as a Binding Motif for hSNF5 and BAF155 Interaction.
    Han J; Kim I; Park JH; Yun JH; Joo K; Kim T; Park GY; Ryu KS; Ko YJ; Mizutani K; Park SY; Seong RH; Lee J; Suh JY; Lee W
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
    Lee D; Sohn H; Kalpana GV; Choe J
    Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.